Related Experiment Video
Updated: Feb 18, 2026

13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
19.5K
Factor VII-Activating Protease: Hemostatic Protein or Immune Regulator?
1Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam, The Netherlands.
Seminars in Thrombosis and Hemostasis
|November 25, 2017
Summary
Factor VII (FVII)-activating protease (FSAP) is a plasma serine protease. This review explores FSAP
Area of Science:
- Biochemistry
- Vascular Biology
- Coagulation Cascade
Background:
- Factor VII (FVII)-activating protease (FSAP) is a plasma serine protease.
- Initially linked to FVII activation and fibrinolysis, recent research questions these roles.
- Emerging evidence suggests FSAP's procoagulant activity via tissue factor pathway inhibitor cleavage and diverse substrate interactions.
Purpose of the Study:
- To review the biochemical properties of FSAP.
- To discuss the regulation of FSAP activation.
- To examine FSAP's role in vascular and inflammatory diseases.
Main Methods:
- Literature review of biochemical and animal studies.
- Analysis of FSAP substrate identification.
- Investigation of FSAP's role in disease pathogenesis.
Main Results:
- FSAP exhibits diverse substrate interactions, including growth factors, histones, and high-molecular-weight kininogen.
- FSAP can induce DNA release from dead cells.
- Animal studies indicate FSAP involvement in arteriosclerosis, vascular integrity, and coagulation regulation.
Conclusions:
- FSAP's function extends beyond initial descriptions, with significant roles in coagulation and inflammation.
- Understanding FSAP activation and regulation is crucial due to its complexity and disease relevance.
- FSAP is implicated in vascular diseases and acute systemic inflammatory conditions like sepsis.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
13.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Clot Retraction and Fibrinolysis
9.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.2K
Introduction to Hemostasis
14.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.9K
Formation of the Platelet Plug
9.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.6K
Coagulation
10.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
10.8K

